CTGF increases vascular endothelial growth factor-dependent angiogenesis in human synovial fibroblasts by increasing miR-210 expression

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Liu, S C ^a   Chuang, S M ^b   Hsu, C J ^a,c   Tsai, C H ^a,c   Wang, S W ^d   Tang, C H ^a,e,f  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d MACKAY MEDICAL COLLEGE   (Taiwan)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

^f ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CONNECTIVE TISSUE GROWTH FACTOR; GLYCEROL 3 PHOSPHATE DEHYDROGENASE; GLYCEROL 3 PHOSPHATE DEHYDROGENASE 1 LIKE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA 210; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; PROTEIN KINASE B; TRANSCRIPTION FACTOR ELK 1; UNCLASSIFIED DRUG; VASCULOTROPIN; EGLN1 PROTEIN, HUMAN; ELK1 PROTEIN, HUMAN; HYPOXIA INDUCIBLE FACTOR PROLINE DIOXYGENASE; MICRORNA; MIRN210 MICRORNA, HUMAN; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; ENZYME INHIBITION; FIBROBLAST; GENE EXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTRACELLULAR SIGNALING; MALE; MOLECULAR PATHOLOGY; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN FUNCTION; PROTEIN SYNTHESIS; SYNOVIAL FIBROBLAST; SYNOVIAL FLUID LEVEL; SYNOVIOCYTE; UPREGULATION; ANGIOGENESIS; BIOLOGICAL MODEL; CASE CONTROL STUDY; GENE SILENCING; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; SYNOVIUM;

MUS MUSCULUS;

CASE-CONTROL STUDIES; CONNECTIVE TISSUE GROWTH FACTOR; ETS-DOMAIN PROTEIN ELK-1; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; GENE KNOCKDOWN TECHNIQUES; HUMANS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; HYPOXIA-INDUCIBLE FACTOR-PROLINE DIOXYGENASES; MICRORNAS; MODELS, BIOLOGICAL; NEOVASCULARIZATION, PHYSIOLOGIC; NF-KAPPA B; OSTEOARTHRITIS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84922029176     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.453     Document Type: Article

References (53)

1. Peat G, McCarney R, Croft P. Knee pain and osteoarthritis in older adults: a review of community burden and current use of primary health care. Ann Rheum Dis 2001; 60: 91-97.
2. Goldring MB, Goldring SR. Osteoarthritis. J Cell Physiol 2007; 213: 626-634.
3. Felson DT. Clinical practice. Osteoarthritis of the knee. N Engl J Med 2006; 354: 841-848.
4. Sellam J, Berenbaum F. The role of synovitis in pathophysiology and clinical symptoms of osteoarthritis. Nat Rev Rheumatol 2010; 6: 625-635.
5. Ashraf S, Walsh DA. Angiogenesis in osteoarthritis. Curr Opin Rheumatol 2008; 20: 573-580.
6. Pufe T, Lemke A, Kurz B, Petersen W, Tillmann B, Grodzinsky AJ et al. Mechanical overload induces VEGF in cartilage discs via hypoxia-inducible factor. Am J Pathol 2004; 164: 185-192.
7. Jansen H, Meffert RH, Birkenfeld F, Petersen W, Pufe T. Detection of vascular endothelial growth factor (VEGF) in moderate osteoarthritis in a rabbit model. Ann Anat 2012; 194: 452-456.
8. Murata M, Yudoh K, Masuko K. The potential role of vascular endothelial growth factor (VEGF) in cartilage: how the angiogenic factor could be involved in the pathogenesis of osteoarthritis? Osteoarthr Cartil 2008; 16: 279-286.
9. Sone H, Kawakami Y, Sakauchi M, Nakamura Y, Takahashi A, Shimano H et al. Neutralization of vascular endothelial growth factor prevents collagen-induced arthritis and ameliorates established disease in mice. Biochem Biophys Res Commun 2001; 281: 562-568.
10. Perbal B. CCN proteins: multifunctional signalling regulators. Lancet 2004; 363: 62-64.
11. Omoto S, Nishida K, Yamaai Y, Shibahara M, Nishida T, Doi T et al. Expression and localization of connective tissue growth factor (CTGF/Hcs24/CCN2) in osteoarthritic cartilage. Osteoarthr Cartil 2004; 12: 771-778.
12. Blaney Davidson EN, Vitters EL, Mooren FM, Oliver N, Berg WB, van der Kraan PM. Connective tissue growth factor/CCN2 overexpression in mouse synovial lining results in transient fibrosis and cartilage damage. Arthritis Rheum 2006; 54: 1653-1661.
13. Honsawek S, Yuktanandana P, Tanavalee A, Chirathaworn C, AnomasiriW, Udomsinprasert W et al. Plasma and synovial fluid connective tissue growth factor levels are correlated with disease severity in patients with knee osteoarthritis. Biomarkers 2012; 17: 303-308.
14. Liu SC, Hsu CJ, Chen HT, Tsou HK, Chuang SM, Tang CH. CTGF increases IL-6 expression in human synovial fibroblasts through integrin-dependent signaling pathway. PLoS One 2012; 7: e51097.
15. Liu SC, Hsu CJ, Fong YC, Chuang SM, Tang CH. CTGF induces monocyte chemoattractant protein-1 expression to enhance monocyte migration in human synovial fibroblasts. Biochim Biophys Acta 2013; 1833: 1114-1124.
16. Ambros V. The functions of animal microRNAs. Nature 2004; 431: 350-355.
17. Calin GA, Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
18. Chan WL, Chan YS, Yang WK, Huang HD, Chang JG. Very long non-coding RNA and human disease. BioMedicine 2012; 2: 167-173.
19. Miyaki S, Asahara H. Macro view of microRNA function in osteoarthritis. Nat Rev Rheumatol 2012; 8: 543-552.
20. van Solingen C, Seghers L, Bijkerk R, Duijs JM, Roeten MK, van Oeveren-Rietdijk AM et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemiainduced angiogenesis. J Cell Mol Med 2009; 13: 1577-1585.
21. Chen Y, Gorski DH. Regulation of angiogenesis through a microRNA (miR-130a) that downregulates antiangiogenic homeobox genes GAX and HOXA5. Blood 2008; 111: 1217-1226.
22. Suarez Y, Fernandez-Hernando C, Pober JS, SessaWC. Dicer dependent microRNAs regulate gene expression and functions in human endothelial cells. Circ Res 2007; 100: 1164-1173.
23. Fasanaro P, D'Alessandra Y, Di Stefano V, Melchionna R, Romani S, Pompilio G et al. MicroRNA-210 modulates endothelial cell response to hypoxia and inhibits the receptor tyrosine kinase ligand Ephrin-A3. J Biol Chem 2008; 283: 15878-15883.
24. Mapp PI, Walsh DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol 2012; 8: 390-398.
25. Brigstock DR. Regulation of angiogenesis and endothelial cell function by connective tissue growth factor (CTGF) and cysteine-rich 61 (CYR61). Angiogenesis 2002; 5: 153-165.
26. Yang F, Tuxhorn JA, Ressler SJ, McAlhany SJ, Dang TD, Rowley DR. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Cancer Res 2005; 65: 8887-8895.
27. Bonnet CS, Walsh DA. Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford) 2005; 44: 7-16.
28. Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature 2000; 407: 249-257.
29. Nakasa T, Nagata Y, Yamasaki K, Ochi M. A mini-review: microRNA in arthritis. Physiol Genomics 2011; 43: 566-570.
30. Iliopoulos D, Malizos KN, Oikonomou P, Tsezou A. Integrative microRNA and proteomic approaches identify novel osteoarthritis genes and their collaborative metabolic and inflammatory networks. PLoS One 2008; 3: e3740.
31. Zhou M, Song X, Huang Y, Wei L, Li Z, You Q et al. Wogonin inhibits H2O2-induced angiogenesis via suppressing PI3K/Akt/NF-kappaB signaling pathway. Vascul Pharmacol 2014; 60: 110-119.
32. Kim MK, Park HJ, Kim YD, Ryu MH, Takata T, Bae SK et al. Hinokitiol increases the angiogenic potential of dental pulp cells through ERK and p38MAPK activation and hypoxiainducible factor-1alpha (HIF-1alpha) upregulation. Arch Oral Biol 2014; 59: 102-110.
33. Kim JH, Park SG, Song SY, Kim JK, Sung JH. Reactive oxygen species-responsive miR-210 regulates proliferation and migration of adipose-derived stem cells via PTPN2. Cell Death Dis 2013; 4: e588.
34. Kelly TJ, Souza AL, Clish CB, Puigserver P. A hypoxia-induced positive feedback loop promotes hypoxia-inducible factor 1alpha stability through miR-210 suppression of glycerol-3-phosphate dehydrogenase 1-like. Mol Cell Biol 2011; 31: 2696-2706.
35. Jaakkola P, Mole DR, Tian YM,Wilson MI, Gielbert J, Gaskell SJ et al. Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation. Science 2001; 292: 468-472.
36. Maa MC, Leu TH. Activation of Toll-like receptors induces macrophage migration via the iNOS/Src/FAK pathway. BioMedicine 2011; 1: 11-15.
37. Haywood L, McWilliams DF, Pearson CI, Gill SE, Ganesan A, Wilson D et al. Inflammation and angiogenesis in osteoarthritis. Arthritis Rheum 2003; 48: 2173-2177.
38. Ashraf S, Mapp PI, Walsh DA. Contributions of angiogenesis to inflammation, joint damage, and pain in a rat model of osteoarthritis. Arthritis Rheum 2011; 63: 2700-2710.
39. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet 2004; 5: 522-531.
40. Yu C, Chen WP, Wang XH. MicroRNA in osteoarthritis. J Int Med Res 2011; 39: 1-9.
41. Taganov KD, Boldin MP, Chang KJ, Baltimore D. NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses. Proc Natl Acad Sci USA 2006; 103: 12481-12486.
42. Stanczyk J, Pedrioli DM, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE et al. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum 2008; 58: 1001-1009.
43. Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C et al. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum 2011; 63: 373-381.
44. Liu F, Lou YL, Wu J, Ruan QF, Xie A, Guo F et al. Upregulation of microRNA-210 regulates renal angiogenesis mediated by activation of VEGF signaling pathway under ischemia/ perfusion injury in vivo and in vitro. Kidney Blood Press Res 2012; 35: 182-191.
45. Chan SY, Loscalzo J. MicroRNA-210: a unique and pleiotropic hypoxamir. Cell Cycle 2010; 9: 1072-1083.
46. Chan YC, Banerjee J, Choi SY, Sen CK. miR-210: the master hypoxamir. Microcirculation 2012; 19: 215-223.
47. Fukuda R, Hirota K, Fan F, Jung YD, Ellis LM, Semenza GL. Insulin-like growth factor 1 induces hypoxia-inducible factor 1-mediated vascular endothelial growth factor expression, which is dependent on MAP kinase and phosphatidylinositol 3-kinase signaling in colon cancer cells. J Biol Chem 2002; 277: 38205-38211.
48. Prasadam I, Zhou Y, Du Z, Chen J, Crawford R, Xiao Y. Osteocyte-induced angiogenesis via VEGF-MAPK-dependent pathways in endothelial cells. Mol Cell Biochem 2014; 386: 15-25.
49. Tang CH, Hsu CJ, Fong YC. The CCL5/CCR5 axis promotes interleukin-6 production in human synovial fibroblasts. Arthritis Rheum 2010; 62: 3615-3624.
50. Wu MH, Huang CY, Lin JA, Wang SW, Peng CY, Cheng HC et al. Endothelin-1 promotes vascular endothelial growth factor-dependent angiogenesis in human chondrosarcoma cells. Oncogene 2014; 33: 1725-1735.
51. Tseng CP, Huang CL, Huang CH, Cheng JC, Stern A, Tseng CH et al. Disabled-2 small interfering RNA modulates cellular adhesive function and MAPK activity during megakaryocytic differentiation of K562 cells. FEBS Lett 2003; 541: 21-27.
52. Chiu YC, Lin CY, Chen CP, Huang KC, Tong KM, Tzeng CY et al. Peptidoglycan enhances IL-6 production in human synovial fibroblasts via TLR2 receptor, focal adhesion kinase, Akt, and AP-1- dependent pathway. J Immunol 2009; 183: 2785-2792.
53. Passaniti A, Taylor RM, Pili R, Guo Y, Long PV, Haney JA et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab Invest 1992; 67: 519-528.